EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

Variation and clinical consequences of wait-times for atrial fibrillation ablation: population level study in Ontario, Canada

Denis Qeska iD, Sheldon M Singh iD, Feng Qiu, Ragavie Manoragavan, Christopher C Cheung iD, Dennis T Ko iD, Maneesh Sud iD, Maria Terricabras iD, Harindra C Wijeysundera iD

Europace · 2023

DOI: 10.1093/europace/euad074 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Europace, 2023. Verfasst von Denis Qeska und 8 weiteren Autor:innen. Beteiligte Einrichtung: Schulich Heart Program, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Ave., Room A202, Toronto, ON M4N 3M5, Canada. Hauptthemen laut MEDLINE: Atrial Fibrillation, Heart Failure, Catheter Ablation. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Jack Tu Chair in Cardiovascular Outcomes Research, University of Toronto, Canada Research Chair in Structural Heart Disease.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Atrial fibrillation (AF) is the most common cardiac rhythm disorder. Emerging evidence supporting the efficacy of catheter ablation in managing AF has led to increased demand for this therapy, potentially outpacing the capacity to perform this procedure. Mismatch between demand and capacity for AF ablation results in wait-times which have not been comprehensively evaluated at a population level. Additionally, the consequences of such delays in AF ablation, namely the risk of hospitalization or adverse events, have not been studied. Methods and results This observational cohort study included adults referred for catheter ablation to treat AF in Ontario, Canada, between 1 April 2016 and 31 March 2020. Wait-time was defined from referral to the earliest of ablation, death, off-list, or the study endpoint of 31 March 2022. The outcomes of interest included a composite of death, hospitalization for AF/heart failure, and emergency department visit for AF/heart failure. Our study cohort included 6253 patients referred for de novo AF ablation. The median wait-time for patients who received and who did not receive ablation was 218 days (IQR: 112–363) and 520 days (IQR: 270–763), respectively. Wait-time increased consistently for patients referred between October 2017 and March 2020. Mortality was rare, but significant morbidity was observed, affecting 19.2% of patients on the waitlist for AF ablation. Paroxysmal AF was associated with a statistically significant greater risk for adverse outcomes on the waitlist (HR 1.51, 95% CI 1.18–1.93).

Conclusion

Wait-times for AF ablation are increasing and are associated with significant morbidity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationHeart FailureCatheter AblationAdultHumansWaiting ListsOntarioTreatment OutcomeRecurrence

Stichwörter der Autor:innen

Atrial fibrillationCatheter ablationWait-times

Autor:innen und Institutionen

  • Schulich Heart Program, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Ave., Room A202, Toronto, ON M4N 3M5, Canada.
  • Temerty Faculty of Medicine, University of Toronto, 1 King's College Circle, Toronto, ON M5S 1A8, Canada.
  • ICES, 2075 Bayview Ave., Room G1 06, Toronto, ON M4N 3M5, Canada.
  • Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College St., Toronto, ON M5T 3M6, Canada.

ORCID-Profile: Denis Qeska, Sheldon M Singh, Christopher C Cheung, Dennis T Ko, Maneesh Sud, Maria Terricabras, Harindra C Wijeysundera

Förderung

  • Jack Tu Chair in Cardiovascular Outcomes Research
  • University of Toronto
  • Canada Research Chair in Structural Heart Disease

Zitieren

APA

Qeska, D., Singh, S. M., Qiu, F., Manoragavan, R., Cheung, C. C., Ko, D. T., Sud, M., Terricabras, M., & Wijeysundera, H. C. (2023). Variation and clinical consequences of wait-times for atrial fibrillation ablation: population level study in Ontario, Canada. Europace. https://doi.org/10.1093/europace/euad074

Vancouver

Qeska D, Singh SM, Qiu F, Manoragavan R, Cheung CC, Ko DT, et al. Variation and clinical consequences of wait-times for atrial fibrillation ablation: population level study in Ontario, Canada. Europace. 2023. doi:10.1093/europace/euad074

BibTeX
@article{Qeska2023,
  author = {Qeska, Denis and Singh, Sheldon M and Qiu, Feng and Manoragavan, Ragavie and Cheung, Christopher C and Ko, Dennis T and Sud, Maneesh and Terricabras, Maria and Wijeysundera, Harindra C},
  title = {Variation and clinical consequences of wait-times for atrial fibrillation ablation: population level study in Ontario, Canada},
  journal = {Europace},
  year = {2023},
  doi = {10.1093/europace/euad074}
}
Kostenlos starten →